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Previewsof the gene-expression changes in the
patient-derived iPSCs, including reducing
expression of the schizophrenia risk gene
TCF4 to normal levels. Again, the avail-
ability of living neurons permitted these
examinations. The ability to differentiate
iPSCs into diverse cell types, including
oligodendrocytes, which have previously
been implicated in schizophrenia (Taka-
hashi et al., 2011), will permit a broad
look at cellular alterations that take place
in psychiatric and neurological diseases.
We can now look forward to amuch better
understanding of the relationship between
genetic risk factors, gene-expression
changes, and neuronal and glial function
in schizophrenia, as well as opportunities
to perform high-throughput screening of
compound libraries in patient-derived
neuronal and glial cells as a step toward
relevant drug discovery.
While this effort from Brennand et al.
(2011) is just a beginning, the now wide-
spread availability of fibroblasts (andother462 Cell Stem Cell 8, May 6, 2011 ª2011 Elscells) from patients with schizophrenia
andother complexdisorderswill undoubt-
edly lead to very large-scale studies using
assays such as those employed by Bren-
nand et al. (2011). The authors suggest
that with the examination of an increasing
number of patient-derived lines, the list of
consistently affected genes will be dimin-
ished. In our opinion, the addition of future
studies will likely lead to subgrouping of
iPSCs, based on the patterns of pathways
that are impacted in each case. In disor-
ders such as schizophrenia with high
heritability, determining the relationship
between the genetic variations present in
the iPSCs that cluster to each of these
subgroups will then permit the prospec-
tive assignment of individual patients to
a given subgroup, based solely on results
of DNA sampling. The opportunity to iden-
tify interventions that are most effective in
specific subgroups represents the ulti-
mate promise of individualized medicine
in complex disease.evier Inc.REFERENCES
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Epithelial plasticity is crucial during embryonic development and progression of carcinomas. In this issue,
Abell et al. (2011) show that acetylation on histones H2A/H2B prevents epithelial cells from undergoing
epithelial-to-mesenchymal transition (EMT). Their findings also suggest that under conditions where EMT
and stemness coexist, they can be independently regulated.Epithelial plasticity is the biologicalmecha-
nism underlying organ formation. During
embryonic development, many tissues
and organs originate after one or several
rounds of EMT and the reverse process,
mesenchymal-to-epithelial transition, or
MET. In adulthood, epithelial homeostasis
is instead important to maintain tissue
architecture, and reactivation of the EMT
program is associated with progression of
carcinomas and organ fibrosis (Thiery
et al., 2009). Recent work suggests that
cancer progression and reactivation ofdevelopmental programs such as EMT
are both associated with acquisition of
stem cell properties. Indeed, poorly differ-
entiated and invasive human tumors in
addition to expressing EMT markers
also show an embryonic stem cell (ESC)
signature (Ben-Porathetal., 2008).Further-
more, inducing EMT inmammary epithelial
cells by overexpressing transcription
factors Snail or Twist has been shown to
confer stem cell properties (Mani et al.,
2008). However, the reverse process,
MET, has also been reported to be animportant component, driving reprogram-
ming of fibroblasts to induced pluripotent
stem cells (iPSCs) (Li et al., 2010; Sama-
varchi-Tehrani et al., 2010), findings which
suggest that the interrelationship between
stem cell properties and EMT or MET is
complex. In this issue of Cell Stem Cell,
Abell et al. (2011) use trophoblast stem
(TS) cells as a model system to confirm
that stem cell properties and EMT signa-
tures coexist in a developmental context
as well as in cancer cells. They also report
that histone 2A/2B acetylation represents
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Previewsa specific epigenetic mark that is lost
during EMT without affecting stem cell
properties, suggesting that EMT and stem-
ness can be independently regulated.
As TS cells differentiate and lose their
stem cell properties, they undergo EMT
and acquire invasive properties to enable
embryo implantation. In vitro, they can be
maintained indefinitely as self-renewing
epithelial colonies in the presence of
FGF4, and removing FGF4 will induce
their differentiation toward placental
subtypes. In previous work, Abell and
colleagues showed that mice with an in-
activating mutation in MAP3K kinase
(KI4/ mice) had abnormal placental
development characterized by increased
trophoblast invasion (Abell et al., 2009).
Trophoblast stem cells derived from the
KI4/ mice, TSKI4 cells, are multipotent
and not only self-renew in the presence
of FGF4, but also exhibit EMT characteris-
tics, suggesting that they represent stem
cells that have lost the epithelial state.
Making use of an invasion assay, Abell
et al. (2011) separated TS cells that had
undergone EMT and compared their
expression profile to that of TSKI4 and
noninvasive TS cells. After clustering of
the results and the generation of Venn
diagrams, the authors found numerous
shared genes, some of them already
known to participate in regulation of the
epithelial phenotype, and others not yet
related to EMT and invasion, which might
be important to analyze during cancer
progression. The authors next looked at
acetylation of histones and found that
although FGF4 withdrawal induced loss
of acetylation on all core histones in wild-
type TS cells, a selective loss of
acetylation on histones H2A and H2B
was observed in the TSKI4 cells. In an
analogous experiment, Abell et al. (2011)
found that TS cells overexpressing
Snail, which also have properties of stem-
ness combined with EMT, also lose this
epigenetic mark. Combining chromatin
immunoprecipitation (ChIP)-seq with
mRNA-seq analysis revealed that loss of
H2B acetylation was associated with
repression of genes required to maintain
the epithelial phenotype. The authors
next identified the histone acetyl trans-
ferase CBP as a candidate regulator in
this context, based on the phenotypic
similarity between MAP3K4 (KI4) andCBP/p300/ mice. Indeed, CBP knock-
down in TS cells induced a selective and
specific loss of the H2A/H2B mark and
an expression profile correlating with the
TSKI4cells. Taken together, thesefindings
suggest that the regulation of H2B/2A
acetylation specifically affects epithelial
plasticity and that the MAP3K4/CBP axis
controls the active chromatin states of
the promoters of ‘‘epithelial’’ genes, main-
taining cells in an epithelial state protected
from undergoing EMT.
An interesting aspect of this work is
that a similar EMT signature and the
absence of the H2BK5Ac epigenetic
mark is also present in a type of breast
cancer, the claudin-low type (CL),
recently shown to exhibit both EMT and
stem-like properties (Prat et al., 2010).
In relation to this, it is interesting to note
that even though breast carcinomas of
the aggressive basal-type undergo EMT
(Sarrio´ et al., 2008), they do not seem to
share the gene signature found both in
the claudin-type and the TS-EMT models
presented in this work, posing the ques-
tion as to whether different carcinoma
types can progress toward the EMT
following different programs.
With respect to the intersection
between EMT and stemness, the findings
of the present work suggest that specific
mechanisms operate to control EMT in
TS cells without affecting stem cell prop-
erties. However, a more detailed under-
standing of the mechanistic relationship
between EMT and stemness is a topic
for future investigation, as even the oper-
ational definition of stem cell properties
varies in different biological contexts.
While embryonic stem cells (ESCs) are
defined by their ability to contribute to all
embryonic lineages, TS cells are multipo-
tent in the sense that they are restricted
to give rise to different extraembryonic
tissues. Cancer stem cells (CSCs), on
the other hand, have characteristics asso-
ciated with normal stem cells, but are
defined by their ability to give rise to all
cell types found in a particular cancer
sample in serial transplants. It is obvious
that these three criteria are not identical
and that the degree of pluripotency varies
depending on the system. Pluripotency
in itself does not seem to be crucial
for cancer progression, as cancer cells
during metastasis formation only revertCell Stem Cto the phenotypes of the primary carci-
noma. Therefore, as pluripotency and
stemness are not interchangeable, the
dynamics of epithelial plasticity and EMT
during either reprogramming to iPSCs or
normal TS differentiation and during
cancer progression may be different
(Ocan˜a and Nieto, 2010). Last, but not
least, it is important to keep in mind
that the process of EMT during both
embryonic development and cancer
progression is usually a transient state
not associated with a particular cell fate,
as MET is necessary for both the forma-
tion of many organs and distant metas-
tasis. In contrast, cell differentiation in
terms of the acquisition of a particular
fate concomitant with the loss of pluripo-
tency is a process that may occur simulta-
neously with EMT, but not necessarily
linked to it. We will surely hear much
more about these crucial issues in the
next few years.REFERENCES
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